Axogen (AXGN) Capital Expenditures (2011 - 2026)
Axogen (AXGN) recorded quarterly Capital Expenditures of $2.8 million in Q1 2026, down 20.52% quarter-over-quarter from $3.5 million in Q4 2025, and up 989.45% on a YoY basis from $256000.0 in Q1 2025.
Axogen (AXGN) Capital Expenditures (2011 - 2026) Analysis & Trends
Axogen's Capital Expenditures history runs 16 years deep, the most recent figure standing at $2.8 million for Q1 2026.
- In Q1 2026, Capital Expenditures rose 989.45% year-over-year to $2.8 million; the TTM figure through Mar 2026 stood at $6.3 million (up 120.98% YoY), while the FY2025 annual figure was $3.7 million, up 20.77% from the prior year.
- Capital Expenditures was $2.8 million for Q1 2026 at Axogen, down from $3.5 million in the prior quarter.
- In the past five years, Capital Expenditures ranged from a high of $13.0 million in Q4 2023 to a low of -$2.5 million in Q2 2023.
- Historically, Capital Expenditures has averaged $2.6 million across 5 years, with a median of $2.3 million in 2024.
- The sharpest annual moves came in 2022 and 2023: Capital Expenditures surged 16655.0% in 2022, then sank 161.4% in 2023.
- A 5-year view of Capital Expenditures shows it stood at $6.6 million in 2022, then surged by 96.6% to $13.0 million in 2023, then slumped by 94.85% to $670000.0 in 2024, then jumped by 423.73% to $3.5 million in 2025, then decreased by 20.52% to $2.8 million in 2026.
- The last three Capital Expenditures figures came in at $2.8 million (Q1 2026), $3.5 million (Q4 2025), and $104000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 399.00 Mn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 166.00 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 444.00 Mn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 177.00 Mn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 64.90 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -85.46 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 76.60 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 86.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 90.20 Mn |
| 10 | Axogen | 2.32 Bn | 2.22 Bn | 46.19 Mn | 2.79 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.79 Mn |
| Mar 31, 2026 | 2.79 Mn |
| Dec 31, 2025 | 3.51 Mn |
| Dec 31, 2025 | 3.51 Mn |
| Sep 30, 2025 | 104,000.00 |
| Sep 30, 2025 | 104,000.00 |
| Jun 30, 2025 | -124,000.00 |
| Jun 30, 2025 | -124,000.00 |
| Mar 31, 2025 | 256,000.00 |
| Mar 31, 2025 | 256,000.00 |
| Dec 31, 2024 | 670,000.00 |
| Dec 31, 2024 | 670,000.00 |
| Sep 30, 2024 | 2.25 Mn |
| Sep 30, 2024 | 2.25 Mn |
| Jun 30, 2024 | -338,000.00 |
| Jun 30, 2024 | -338,000.00 |
| Mar 31, 2024 | 516,000.00 |
| Mar 31, 2024 | 516,000.00 |
| Dec 31, 2023 | 13.02 Mn |
| Dec 31, 2023 | 13.02 Mn |